CT-868
A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
Carmot Therapeutics, Inc · Phase 1 · Completed · Enrollment 32
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| CT-868 | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
| Active Comparator | n/r | n/r | n/r | n/r |
Not shown
- CT-868: endpoint not reported
- Placebo: endpoint not reported
- Active Comparator: endpoint not reported